TY  - GEN
AU  - van der Kolk,L E
AU  - Grillo-López,A J
AU  - Baars,J W
AU  - van Oers,M H J
TI  - Treatment of relapsed B-cell non-Hodgkin's lymphoma with a combination of chimeric anti-CD20 monoclonal antibodies (rituximab) and G-CSF: final report on safety and efficacy
SN  - 0887-6924
PY  - 2003///1106
KW  - Adult
KW  - Aged
KW  - Antibodies, Monoclonal
KW  - administration & dosage
KW  - Antibodies, Monoclonal, Murine-Derived
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - therapeutic use
KW  - Dose-Response Relationship, Drug
KW  - Granulocyte Colony-Stimulating Factor
KW  - Humans
KW  - Lactoferrin
KW  - blood
KW  - Leukocyte Elastase
KW  - Lymphoma, B-Cell
KW  - drug therapy
KW  - Middle Aged
KW  - Neutrophil Activation
KW  - drug effects
KW  - Recurrence
KW  - Remission Induction
KW  - Rituximab
N1  - Publication Type: Clinical Trial; Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article
UR  - https://doi.org/10.1038/sj.leu.2402995
ER  -